INSUBCONTINENT EXCLUSIVE:
New findings from the Phase 3 trial being run by the University of Oxford have revealed that the vaccine is 70.4% effective in stopping
coronavirus, but not as effective as Pfizer's which rolled out today
This article first appeared/also appeared in Mirror
